David S. Hong MD (@davidhongmd) 's Twitter Profile
David S. Hong MD

@davidhongmd

MD Anderson Cancer Center medical oncologist, Deputy Chair of Dept. Investigational Cancer Therapeutics. Phase I clinical trials.Tweets are mine.

ID: 4912387590

linkhttp://faculty.mdanderson.org/david_hong/ calendar_today15-02-2016 19:06:23

2,2K Tweet

3,3K Takipçi

957 Takip Edilen

Springer Healthcare Education (@springermeded) 's Twitter Profile Photo

Discover best pathologic practices within NSCLC and thyroid cancer, as well as insights into how genomic testing can improve outcomes in this expert-led interactive webinar.

MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

Presented by Dr. Tim Yap at #ASCO25: BNT142, a bispecific antibody therapy, shows manageable safety and early anti-tumor activity in CLDN6-positive cancers, including ovarian and testicular tumors. First-in-human results are encouraging. #EndCancer

Presented by Dr. Tim Yap at #ASCO25: BNT142, a bispecific antibody therapy, shows manageable safety and early anti-tumor activity in CLDN6-positive cancers, including ovarian and testicular tumors. First-in-human results are encouraging. #EndCancer
Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

The most practice changing trial from #ASCO25 is now live on <a href="/NEJM/">NEJM</a> .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. 
Perfect case example of a #cancergroundshot trial.
A.n.n. (@fireflyann) 's Twitter Profile Photo

A Phase 1/​2a Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221 Sites in TN, TX and WA clinicaltrials.gov/study/NCT07020… Verastem #ASCO25 slide deck investor.verastem.com/static-files/9… David S. Hong MD CrozrX

A Phase 1/​2a Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
NCT07020221
Sites in TN, TX and WA
clinicaltrials.gov/study/NCT07020…

Verastem #ASCO25 slide deck
investor.verastem.com/static-files/9…

<a href="/DavidHongMD/">David S. Hong MD</a> <a href="/CrozrX/">CrozrX</a>
David S. Hong MD (@davidhongmd) 's Twitter Profile Photo

Congrats to Dr Tara Davidson, and Dr Derrick Tao and missing in this picture Dr Kunwha Kim for finishing your Med Onc fellowship at MD Anderson Cancer Center! It was an honor to have mentored you all! God Speed and God Bless! I look forward to your success!

Congrats to Dr Tara Davidson, and Dr Derrick Tao and missing in this picture Dr Kunwha Kim for finishing your Med Onc fellowship at <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>! It was an honor to have mentored you all! God Speed and God Bless! I look forward to your success!
OncLive.com (@onclive) 's Twitter Profile Photo

In a interview, David S. Hong MD detailed: ⭐️ The implications of the full FDA approval of larotrectinib ⭐️ His experience administering the agent to patients ⭐️ The importance of testing patients for alterations such as NTRK fusions Read more: hubs.li/Q03rltJ-0

David S. Hong MD (@davidhongmd) 's Twitter Profile Photo

If you are ever in Minnetonka, MN and ever need to goto the best steakhouse in the MN stop by Gianni’s! Terri’s Mark Fox was a wonderful pt of mine on a 1st in human trial and both their sacrifice will impact future pts to come! (shared with permission)!

If you are ever in Minnetonka, MN and ever need to goto the best steakhouse in the MN stop by Gianni’s! Terri’s Mark Fox was a wonderful pt of mine on a 1st in human trial and both their sacrifice  will impact future  pts to come!   (shared with permission)!
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

Had a conversation with someone outside of healthcare recently who was shocked by how long it takes to run clinical trials in the U.S (not to mention expensive). I tried to explain—it’s not just the science. It’s the infrastructure. Every site needs dozens of personnel, many of

Had a conversation with someone outside of healthcare recently who was shocked by how long it takes to run clinical trials in the U.S (not to mention expensive).

I tried to explain—it’s not just the science. It’s the infrastructure. Every site needs dozens of personnel, many of